Endothelial glycocalyx dysfunction in disease: Albuminuria and increased microvascular permeability

Journal of Pathology

Volumn 226, Issue 4, 2012, Pages 562-574

  Salmon, Andrew Hj ^a   Satchell, Simon C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

albuminuria; dengue; diabetes; diabetic nephropathy; endothelium; glomerulus; glycocalyx; ischaemia reperfusion injury; permeability; proteinuria

Indexed keywords

GLYCOSAMINOGLYCAN; PROTEOGLYCAN;

ALBUMINURIA; ATHEROSCLEROSIS; BASEMENT MEMBRANE; BLOOD VESSEL PERMEABILITY; CAPILLARY; CAPILLARY WALL; CELL INTERACTION; DIABETES MELLITUS; ENDOTHELIUM CELL; ENDOTHELIUM LESION; FENESTRATION; GLOMERULUS; GLYCOCALYX; HUMAN; INFECTION; ISCHEMIA; LEUKOCYTE; MACROMOLECULE; MECHANOTRANSDUCTION; MICROCIRCULATION; MICROVASCULATURE; NONHUMAN; PATHOPHYSIOLOGY; PERICYTE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VASCULAR ENDOTHELIUM;

ALBUMINURIA; ANIMALS; CAPILLARIES; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GLYCOCALYX; HUMANS; KIDNEY GLOMERULUS; MICROCIRCULATION;

EID: 84856708866     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3964     Document Type: Review

References (141)

1. Haraldsson B, Nystrom J, Deen WM,. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008; 88: 451-487. (Pubitemid 351522745)
2. Pries AR, Secomb TW, Gaehtgens P,. The endothelial surface layer. Pflugers Arch 2000; 440: 653-666.
3. Reitsma S, Slaaf DW, Vink H, et al., The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 2007; 454: 345-359. (Pubitemid 46742429)
4. Weinbaum S, Tarbell JM, Damiano ER,. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 2007; 9: 121-167. (Pubitemid 350246654)
5. Risau W,. Development and differentiation of endothelium. Kidney Int Suppl 1998; 67: S3-6. (Pubitemid 28405671)
6. Roberts WG, Palade GE,. Endothelial fenestrae and fenestral diaphragms. In Morphogenesis of Endothelium, Risau W, Rubanyi GM, (eds). Harwood Academic: Amsterdam, 2000; 23-41.
7. Satchell SC, Braet F,. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol 2009; 296: F947-956.
8. Ichimura K, Stan RV, Kurihara H, et al., Glomerular endothelial cells form diaphragms during development and pathologic conditions. J Am Soc Nephrol 2008; 19: 1463-1471.
9. Friden V, Oveland E, Tenstad O, et al., The glomerular endothelial cell coat is essential for glomerular filtration. Kidney Int 2011; 79: 1322-1330.
10. Adamson RH, Clough G,. Plasma proteins modify the endothelial cell glycocalyx of frog mesenteric microvessels. J Physiol 1992; 445: 473-486.
11. Ebong EE, Macaluso FP, Spray DC, et al., Imaging the endothelial glycocalyx in vitro by rapid freezing/freeze substitution transmission electron microscopy. Arterioscler Thromb Vasc Biol 2011; 31: 1908-1915.
12. Luft JH,. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed Proc 1966; 25: 1773-1783.
13. Arisaka T, Mitsumata M, Kawasumi M, et al., Effects of shear stress on glycosaminoglycan synthesis in vascular endothelial cells. Ann NY Acad Sci 1995; 748: 543-554.
14. Mulivor AW, Lipowsky HH,. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol 2004; 286: H1672-1680. (Pubitemid 38525453)
15. Levick JR, Smaje LH,. An analysis of the permeability of a fenestra. Microvasc Res 1987; 33: 233-256. (Pubitemid 17065262)
16. Dejana E, Tournier-Lasserve E, Weinstein BM,. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009; 16: 209-221.
17. Abbott NJ, Patabendige AA, Dolman DE, et al., Structure and function of the blood-brain barrier. Neurobiol Dis 2010; 37: 13-25.
18. Abbott NJ, Ronnback L, Hansson E,. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7: 41-53. (Pubitemid 41828930)
19. Erickson KK, Sundstrom JM, Antonetti DA,. Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis 2007; 10: 103-117. (Pubitemid 46440630)
20. Simionescu M, Simionescu N,. Ultrastructure of the microvascular wall: functional correlations. In Handbook of Physiology, Renkin EM, Michel CC, (eds). American Physiological Society: Bethesda, MD, 1984; 41-101.
21. LeBleu VS, Macdonald B, Kalluri R,. Structure and function of basement membranes. Exp Biol Med (Maywood) 2007; 232: 1121-1129. (Pubitemid 47503053)
22. Kruegel J, Miosge N,. Basement membrane components are key players in specialized extracellular matrices. Cell Mol Life Sci 2010; 67: 2879-2895.
23. Frank RN, Dutta S, Mancini MA,. Pericyte coverage is greater in the retinal than in the cerebral capillaries of the rat. Invest Ophthalmol Vis Sci 1987; 28: 1086-1091. (Pubitemid 17089946)
24. Tilton RG, Kilo C, Williamson JR,. Pericyte-endothelial relationships in cardiac and skeletal muscle capillaries. Microvasc Res 1979; 18: 325-335. (Pubitemid 10180864)
25. Allt G, Lawrenson JG,. Pericytes: cell biology and pathology. Cells Tissues Organs 2001; 169: 1-11. (Pubitemid 32437039)
26. Kutcher ME, Herman IM,. The pericyte: cellular regulator of microvascular blood flow. Microvasc Res 2009; 77: 235-246.
27. Rostgaard J, Qvortrup K,. Electron microscopic demonstrations of filamentous molecular sieve plugs in capillary fenestrae. Microvasc Res 1997; 53: 1-13. (Pubitemid 27204878)
28. Stan RV, Tkachenko E, Niesman IR,. PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms. Mol Biol Cell 2004; 15: 3615-3630. (Pubitemid 38989701)
29. Avasthi PS, Koshy V,. The anionic matrix at the rat glomerular endothelial surface. Anat Rec 1988; 220: 258-266.
30. Bulger RE, Eknoyan G, Purcell DJd, et al., Endothelial characteristics of glomerular capillaries in normal, mercuric chloride-induced, and gentamicin-induced acute renal failure in the rat. J Clin Invest 1983; 72: 128-141. (Pubitemid 13026636)
31. Deen WM, Lazzara MJ, Myers BD,. Structural determinants of glomerular permeability. Am J Physiol Renal Physiol 2001; 281: F579-596.
32. Satchell SC, Tooke JE,. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 2008; 51: 714-725.
33. Kriz W, Kaissling B,. Structural organization of the mammalian kidney. In The Kidney: Physiology and Pathophysiology, Seldin D, Giebisch G, (eds). Raven: New York, 1992; 707-777.
34. Miner JH,. Glomerular basement membrane composition and the filtration barrier. Pediatr Nephrol 2011; 26: 1413-1417.
35. Miner JH,. Renal basement membrane components. Kidney Int 1999; 56: 2016-2024. (Pubitemid 30004730)
36. Pavenstadt H, Kriz W, Kretzler M,. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83: 253-307. (Pubitemid 36459882)
37. Gagliardini E, Conti S, Benigni A, et al., Imaging of the porous ultrastructure of the glomerular epithelial filtration slit. J Am Soc Nephrol 2010; 21: 2081-2089.
38. Rodewald R, Karnovsky MJ,. Porous substructure of the glomerular slit diaphragm in the rat and mouse. J Cell Biol 1974; 60: 423-433.
39. Neal CR, Crook H, Bell E, et al., Three-dimensional reconstruction of glomeruli by electron microscopy reveals a distinct restrictive urinary subpodocyte space. J Am Soc Nephrol 2005; 16: 1223-1235. (Pubitemid 41716507)
40. Neal CR, Muston PR, Njegovan D, et al., Glomerular filtration into the subpodocyte space is highly restricted under physiological perfusion conditions. Am J Physiol Renal Physiol 2007; 293: F1787-1798. (Pubitemid 350179603)
41. Salmon AH, Toma I, Sipos A, et al., Evidence for restriction of fluid and solute movement across the glomerular capillary wall by the subpodocyte space. Am J Physiol Renal Physiol 2007; 293: F1777-1786. (Pubitemid 350179602)
42. Eremina V, Baelde HJ, Quaggin SE,. Role of the VEGF-a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 2007; 106: 32-37.
43. Curry FR, Adamson RH,. Vascular permeability modulation at the cell, microvessel, or whole organ level: towards closing gaps in our knowledge. Cardiovasc Res 2010; 87: 218-229.
44. Levick JR, Michel CC,. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 2010; 87: 198-210.
45. Michel CC, Curry FE,. Microvascular permeability. Physiol Rev 1999; 79: 703-761. (Pubitemid 29330172)
46. Adamson RH, Michel CC,. Pathways through the intercellular clefts of frog mesenteric capillaries. J Physiol 1993; 466: 303-327. (Pubitemid 23225231)
47. Bundgaard M,. The three-dimensional organization of tight junctions in a capillary endothelium revealed by serial-section electron microscopy. J Ultrastruct Res 1984; 88: 1-17. (Pubitemid 15155109)
48. Adamson RH,. Permeability of frog mesenteric capillaries after partial pronase digestion of the endothelial glycocalyx. J Physiol 1990; 428: 1-13. (Pubitemid 20313642)
49. Curry FE, Michel CC,. A fiber matrix model of capillary permeability. Microvasc Res 1980; 20: 96-99. (Pubitemid 10087148)
50. Weinbaum S,. 1997 Whitaker Distinguished Lecture: models to solve mysteries in biomechanics at the cellular level; a new view of fiber matrix layers. Ann Biomed Eng 1998; 26: 627-643. (Pubitemid 128609662)
51. Hu X, Adamson RH, Liu B, et al., Starling forces that oppose filtration after tissue oncotic pressure is increased. Am J Physiol Heart Circ Physiol 2000; 279: H1724-1736.
52. Adamson RH, Lenz JF, Zhang X, et al., Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol 2004; 557: 889-907. (Pubitemid 38961624)
53. Curry FR,. Microvascular solute and water transport. Microcirculation 2005; 12: 17-31.
54. Michel CC, Phillips ME,. Steady-state fluid filtration at different capillary pressures in perfused frog mesenteric capillaries. J Physiol 1987; 388: 421-435. (Pubitemid 17103506)
55. Deen WM, Troy JL, Robertson CR, et al., Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiltration coefficient. J Clin Invest 1973; 52: 1500-1508.
56. Chang RL, Ueki IF, Troy JL, et al., Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran. Biophys J 1975; 15: 887-906.
57. Lund U, Rippe A, Venturoli D, et al., Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys. Am J Physiol Renal Physiol 2003; 284: F1226-1234. (Pubitemid 36578450)
58. Rippe C, Asgeirsson D, Venturoli D, et al., Effects of glomerular filtration rate on Ficoll sieving coefficients (θ) in rats. Kidney Int 2006; 69: 1326-1332.
59. Deen WM, Robertson CR, Brenner BM,. Concentration polarization in an ultrafiltering capillary. Biophys J 1974; 14: 412-431.
60. Michel CC,. Capillary permeability and how it may change. J Physiol 1988; 404: 1-29.
61. Bankston PW, Milici AJ,. A survey of the binding of polycationic ferritin in several fenestrated capillary beds: indication of heterogeneity in the luminal glycocalyx of fenestral diaphragms. Microvasc Res 1983; 26: 36-48. (Pubitemid 13026418)
62. Squire JM, Chew M, Nneji G, et al., Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? J Struct Biol 2001; 136: 239-255.
63. Arkill KP, Knupp C, Michel CC, et al., Similar endothelial glycocalyx structures in microvessels from a range of mammalian tissues: evidence for a common filtering mechanism? Biophys J 2011; 101: 1046-1056.
64. Michel CC,. Capillary exchange. In The Kidney: Physiology and Pathophysiology, Seldin DW, Giebsich G, (eds). Raven: New York, 1992; 61-91.
65. Ishibashi T, Inomata H,. Ultrastructure of retinal vessels in diabetic patients. Br J Ophthalmol 1993; 77: 574-578. (Pubitemid 23281458)
66. Wallow IH, Engerman RL,. Permeability and patency of retinal blood vessels in experimental diabetes. Invest Ophthalmol Vis Sci 1977; 16: 447-461. (Pubitemid 8108646)
67. Adamson RH, Zeng M, Adamson GN, et al., PAF- and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction. Am J Physiol Heart Circ Physiol 2003; 285: H406-417. (Pubitemid 36736456)
68. Kumar P, Shen Q, Pivetti CD, et al., Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med 2009; 11: e19.
69. Boute N, Gribouval O, Roselli S, et al., NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000; 24: 349-354. (Pubitemid 30187431)
70. Kestila M, Lenkkeri U, Mannikko M, et al., Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1: 575-582. (Pubitemid 128374693)
71. -/- mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest 2006; 116: 2272-2279. (Pubitemid 44162337)
72. Lafayette RA, Druzin M, Sibley R, et al., Nature of glomerular dysfunction in pre-eclampsia. Kidney Int 1998; 54: 1240-1249. (Pubitemid 28449911)
73. Toyoda M, Najafian B, Kim Y, et al., Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 2007; 56: 2155-2160. (Pubitemid 47195834)
74. Yamamoto I, Horita S, Takahashi T, et al., Glomerular expression of plasmalemmal vesicle-associated protein-1 in patients with transplant glomerulopathy. Am J Transpl 2007; 7: 1954-1960. (Pubitemid 47037986)
75. Wavamunno MD, O'Connell PJ, Vitalone M, et al., Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transpl 2007; 7: 2757-2768. (Pubitemid 350045771)
76. Eremina V, Jefferson JA, Kowalewska J, et al., VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008; 358: 1129-1136. (Pubitemid 351398487)
77. Huxley VH, Williams DA,. Role of a glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments. Am J Physiol Heart Circ Physiol 2000; 278: H1177-1185. (Pubitemid 30235494)
78. Salmon AH, Neal CR, Sage LM, et al., Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx. Cardiovasc Res 2009; 83: 24-33.
79. Jeansson M, Haraldsson B,. Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. J Am Soc Nephrol 2003; 14: 1756-1765. (Pubitemid 36750471)
80. Jeansson M, Haraldsson B,. Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am J Physiol Renal Physiol 2006; 290: F111-116.
81. Meuwese MC, Broekhuizen LN, Kuikhoven M, et al., Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein E-deficient mice. PLoS One 2010; 5: e14262.
82. Gelberg H, Healy L, Whiteley H, et al., In vivo enzymatic removal of α2-6-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury. Lab Invest 1996; 74: 907-920. (Pubitemid 26152660)
83. Bakker WW, Borghuis T, Harmsen MC, et al., Protease activity of plasma hemopexin. Kidney Int 2005; 68: 603-610. (Pubitemid 43323115)
84. Singh A, Satchell SC, Neal CR, et al., Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol 2007; 18: 2885-2893. (Pubitemid 350058395)
85. Lennon R, Singh A, Welsh GI, et al., Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes. J Am Soc Nephrol 2008; 19: 2140-2149.
86. Jeansson M, Granqvist AB, Nystrom JS, et al., Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice. Diabetologia 2006; 49: 2200-2209. (Pubitemid 44168489)
87. Satoh M, Kobayashi S, Kuwabara A, et al., In vivo visualization of glomerular microcirculation and hyperfiltration in streptozotocin-induced diabetic rats. Microcirculation 2010; 17: 103-112.
88. Kuwabara A, Satoh M, Tomita N, et al., Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 2010; 53: 2056-2065.
89. Singh A, Friden V, Dasgupta I, et al., High glucose causes dysfunction of the human glomerular endothelial glycocalyx. Am J Physiol Renal Physiol 2011; 300: F40-48.
90. Deckert T, Kofoed-Enevoldsen A, Vidal P, et al., Size- and charge selectivity of glomerular filtration in type 1 (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 1993; 36: 244-251. (Pubitemid 23067087)
91. Lemley KV, Blouch K, Abdullah I, et al., Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol 2000; 11: 2095-2105.
92. Jeansson M, Bjorck K, Tenstad O, et al., Adriamycin alters glomerular endothelium to induce proteinuria. J Am Soc Nephrol 2009; 20: 114-122.
93. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, et al., Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-226. (Pubitemid 19136363)
94. Daneman D,. Type 1 diabetes. Lancet 2006; 367: 847-858. (Pubitemid 43363372)
95. Stehouwer CD,. Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease. Nephrol Dialysis Transpl 2004; 19: 778-781. (Pubitemid 38455645)
96. Tooke JE,. Microvascular function in human diabetes: a physiological perspective. Diabetes 1995; 44: 721-726.
97. Yuan SY, Ustinova EE, Wu MH, et al., Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes. Circ Res 2000; 87: 412-417.
98. Perrin RM, Harper SJ, Corrall R, et al., Hyperglycemia stimulates a sustained increase in hydraulic conductivity in vivo without any change in reflection coefficient. Microcirculation 2007; 14: 683-696. (Pubitemid 47434285)
99. Jaap AJ, Shore AC, Gartside IB, et al., Increased microvascular fluid permeability in young type 1 (insulin-dependent) diabetic patients. Diabetologia 1993; 36: 648-652. (Pubitemid 23186458)
100. Jaap AJ, Shore AC, Tooke JE,. Differences in microvascular fluid permeability between long-duration type I (insulin-dependent) diabetic patients with and without significant microangiopathy. Clin Sci (Lond) 1996; 90: 113-117. (Pubitemid 26034716)
101. Nieuwdorp M, Mooij HL, Kroon J, et al., Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 2006; 55: 1127-1132. (Pubitemid 44100191)
102. Broekhuizen LN, Lemkes BA, Mooij HL, et al., Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia 2010; 53: 2646-2655.
103. Michel CC, Curry FR,. Glycocalyx volume: a critical review of tracer dilution methods for its measurement. Microcirculation 2009; 16: 213-219.
104. Yuan SY, Breslin JW, Perrin R, et al., Microvascular permeability in diabetes and insulin resistance. Microcirculation 2007; 14: 363-373. (Pubitemid 47050028)
105. Schreibelt G, Kooij G, Reijerkerk A, et al., Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 2007; 21: 3666-3676. (Pubitemid 350075154)
106. Rubio-Gayosso I, Platts SH, Duling BR,. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006; 290: H2247-2256. (Pubitemid 43846051)
107. Singh A, Friden V, Dasgupta I, et al., High glucose causes dysfunction of the human glomerular endothelial glycocalyx. Am J Physiol Renal Physiol 2011; 300: F40-48.
108. Norwood MG, Sayers RD,. Urinary albumin:creatinine ratio (ACR) and the prediction of postoperative complications after abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2005; 30: 353-358. (Pubitemid 41258492)
109. Smith FC, Gosling P, Sanghera K, et al., Microproteinuria predicts the severity of systemic effects of reperfusion injury following infrarenal aortic aneurysm surgery. Ann Vasc Surg 1994; 8: 1-5. (Pubitemid 24080619)
110. Andersson M, Nilsson U, Hjalmarsson C, et al., Mild renal ischemia-reperfusion reduces charge and size selectivity of the glomerular barrier. Am J Physiol Renal Physiol 2007; 292: F1802-1809. (Pubitemid 47105370)
111. Rehm M, Bruegger D, Christ F, et al., Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116: 1896-1906. (Pubitemid 350287085)
112. Snoeijs MG, Vink H, Voesten N, et al., Acute ischemic injury to the renal microvasculature in human kidney transplantation. Am J Physiol Renal Physiol 2010; 299: F1134-1140.
113. Kozar RA, Peng Z, Zhang R, et al., Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 2011; 112: 1289-1295.
114. Chappell D, Jacob M, Hofmann-Kiefer K, et al., Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007; 107: 776-784. (Pubitemid 351325970)
115. Chappell D, Hofmann-Kiefer K, Jacob M, et al., TNFα-induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol 2009; 104: 78-89.
116. Trung DT, Wills B,. Systemic vascular leakage associated with dengue infections-the clinical perspective. Curr Top Microbiol Immunol 2010; 338: 57-66.
117. Statler J, Mammen M, Lyons A, et al., Sonographic findings of healthy volunteers infected with dengue virus. J Clin Ultrasound 2008; 36: 413-417.
118. Bethell DB, Gamble J, Pham PL, et al., Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin Infect Dis 2001; 32: 243-253. (Pubitemid 32524794)
119. Wills BA, Oragui EE, Dung NM, et al., Size and charge characteristics of the protein leak in dengue shock syndrome. J Infect Dis 2004; 190: 810-818. (Pubitemid 39050012)
120. Oragui EE, Nadel S, Kyd P, et al., Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria. Crit Care Med 2000; 28: 3002-3008.
121. Marechal X, Favory R, Joulin O, et al., Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008; 29: 572-576. (Pubitemid 351544076)
122. Nelson A, Berkestedt I, Schmidtchen A, et al., Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 2008; 30: 623-627.
123. Steppan J, Hofer S, Funke B, et al., Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. J Surg Res 2011; 165: 136-141.
124. Chappell D, Westphal M, Jacob M,. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 2009; 22: 155-162.
125. De Gaudio AR, Adembri C, Grechi S, et al., Microalbuminuria as an early index of impairment of glomerular permeability in postoperative septic patients. Intens Care Med 2000; 26: 1364-1368.
126. Stehouwer CD, Smulders YM,. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 2006; 17: 2106-2111. (Pubitemid 44141899)
127. Constantinescu AA, Vink H, Spaan JA,. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol 2003; 23: 1541-1547. (Pubitemid 37108195)
128. Mulivor AW, Lipowsky HH,. Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol 2002; 283: H1282-1291.
129. Joussen A, Poulaki V, Tsujikawa A, et al., Supression of diabetic retinopathy with angiopoietin-1. Am J Pathol 2002; 160: 1683-1693.
130. Galkina E, Ley K,. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 2006; 17: 368-377.
131. Gamble JR, Drew J, Trezise L, et al., Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 2000; 87: 603-607.
132. Nagy N, Freudenberger T, Melchior-Becker A, et al., Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: novel insights into the role of hyaluronan synthesis. Circulation 2010; 122: 2313-2322.
133. Liu JE, Robbins DC, Palmieri V, et al., Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J Am Coll Cardiol 2003; 41: 2022-2028. (Pubitemid 36677126)
134. Arnold JM, Yusuf S, Young J, et al., Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003; 107: 1284-1290. (Pubitemid 36314412)
135. Katare RG, Caporali A, Oikawa A, et al., Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway. Circ Heart Fail 2010; 3: 294-305.
136. Fang ZY, Prins JB, Marwick TH,. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004; 25: 543-567. (Pubitemid 39096070)
137. Becker BF, Chappell D, Bruegger D, et al., Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 2010; 87: 300-310.
138. Jacob M, Bruegger D, Rehm M, et al., The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 2007; 73: 575-586. (Pubitemid 46073952)
139. Dongaonkar RM, Stewart RH, Geissler HJ, et al., Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function. Cardiovasc Res 2010; 87: 331-339.
140. Noble MI, Drake-Holland AJ, Vink H,. Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process. QJM 2008; 101: 513-518. (Pubitemid 351911993)
141. Rostgaard J, Qvortrup K, Poulsen SS,. Improvements in the technique of vascular perfusion-fixation employing a fluorocarbon-containing perfusate and a peristaltic pump controlled by pressure feedback. J Microsc 1993; 172: 137-151. (Pubitemid 23354931)